These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Ra SW; Lyu J; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS Int J Tuberc Lung Dis; 2011 May; 15(5):635-40. PubMed ID: 21756514 [TBL] [Abstract][Full Text] [Related]
4. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Soysal A; Torun T; Efe S; Gencer H; Tahaoglu K; Bakir M Int J Tuberc Lung Dis; 2008 Jan; 12(1):50-6. PubMed ID: 18173877 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic usefulness of the tuberculin reaction by PPD-B in Mycobacterium avium complex disease]. Harada Y; Harada S; Kajiki A; Kitahara Y; Takamoto M; Ishibashi T Kekkaku; 1998 May; 73(5):349-53. PubMed ID: 9637819 [TBL] [Abstract][Full Text] [Related]
7. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978 [TBL] [Abstract][Full Text] [Related]
8. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Kitada S; Maekura R; Toyoshima N; Fujiwara N; Yano I; Ogura T; Ito M; Kobayashi K Clin Infect Dis; 2002 Dec; 35(11):1328-35. PubMed ID: 12439795 [TBL] [Abstract][Full Text] [Related]
9. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730 [TBL] [Abstract][Full Text] [Related]
10. Serodiagnostic contributions of antibody titers against mycobacterial lipid antigens in Mycobacterium avium complex pulmonary disease. Nishimura T; Hasegawa N; Fujita Y; Yano I; Ishizaka A Clin Infect Dis; 2009 Aug; 49(4):529-35. PubMed ID: 19591595 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of the T-SPOT.TB assay for the immunodiagnosis of smear-positive pulmonary tuberculosis using induced sputum. Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FO Int J Tuberc Lung Dis; 2010 Sep; 14(9):1205-8. PubMed ID: 20819270 [TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. Jun HJ; Jeon K; Um SW; Kwon OJ; Lee NY; Koh WJ Respir Med; 2009 Dec; 103(12):1936-40. PubMed ID: 19576745 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of non-tuberculous pulmonary mycobacteriosis]. Sakatani M; Nakajima Y Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy. Zhang LF; Liu XQ; Zuo LY; Li TS; Deng GH; Wang AX Chin Med J (Engl); 2010 May; 123(9):1117-21. PubMed ID: 20529548 [TBL] [Abstract][Full Text] [Related]
16. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
17. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Dheda K; van Zyl-Smit RN; Meldau R; Meldau S; Symons G; Khalfey H; Govender N; Rosu V; Sechi LA; Maredza A; Semple P; Whitelaw A; Wainwright H; Badri M; Dawson R; Bateman ED; Zumla A Thorax; 2009 Oct; 64(10):847-53. PubMed ID: 19592392 [TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M Scand J Infect Dis; 2008; 40(8):629-34. PubMed ID: 18642159 [TBL] [Abstract][Full Text] [Related]
19. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. von Reyn CF; Horsburgh CR; Olivier KN; Barnes PF; Waddell R; Warren C; Tvaroha S; Jaeger AS; Lein AD; Alexander LN; Weber DJ; Tosteson AN Int J Tuberc Lung Dis; 2001 Dec; 5(12):1122-8. PubMed ID: 11769770 [TBL] [Abstract][Full Text] [Related]
20. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]